SEC Form 8-K Summary
Registrant: Brilliant Acquisition Corporation; the provided metadata identifies T3 Defense Inc., but the filing itself names Brilliant Acquisition Corporation.
Reporting event: February 22, 2022; the report was signed and dated February 23, 2022. This is a transaction announcement, not a periodic financial report.
Business Context and Transaction
Brilliant entered into an Agreement and Plan of Merger with Nukkleus Inc. Nukkleus will form a wholly owned British Virgin Islands subsidiary that will merge with Brilliant. Following the transaction, Nukkleus is expected to become the Nasdaq-listed parent company, referred to as PubCo.
- Assuming no redemptions from Brilliant’s trust account, former Nukkleus shareholders are expected to own approximately 66% and former Brilliant shareholders approximately 34% of PubCo’s outstanding ordinary shares immediately after closing.
- Closing was expected in the second quarter of 2022, subject to shareholder approvals, an effective registration statement, Nasdaq approval, and other customary conditions.
- Nukkleus was expected to seek approval for a reverse stock split designed to result in approximately 14.0 million Nukkleus common shares outstanding immediately before closing; the anticipated ratio was approximately 1-for-26.227, subject to change.
Financial Metrics, Capitalization, and Liquidity
The filing does not provide revenue, net income, cash flow, margins, debt balances, or other periodic operating results.
- A closing condition requires Nukkleus to have at least $10.0 million of gross cash and cash equivalents available immediately after closing, including trust-fund proceeds and before transaction costs.
- The filing does not state the trust-account balance, expected redemption level, transaction value, total consideration, or pro forma capitalization.
- Brilliant’s unpaid debt, excluding specified transaction costs, must remain below a threshold specified in the Merger Agreement; the filing text does not provide that threshold.
Security Treatment and Material Terms
- Each Brilliant public share generally converts into one PubCo share plus a pro rata allocation of the Backstop Pool, while shares held by Brilliant initial shareholders generally convert into one PubCo share.
- The Backstop Pool equals the lower of 506,000 PubCo shares and 20% of the aggregate number of outstanding SPAC shares and rights immediately before closing.
- Each SPAC right generally converts into 0.1 PubCo share plus a pro rata allocation of the Backstop Pool, with different treatment for initial shareholders.
- SPAC warrants will be assumed by PubCo. For non-initial-shareholder warrants, the number of warrants and exercise price will be adjusted by the applicable exchange ratio; the original stated exercise price was $11.50 per share before adjustment.
- Certain Nukkleus shareholders agreed to support and vote for the transaction and refrain from transactions involving Brilliant securities before closing.
- Certain Brilliant shareholders will be subject to one-year transfer restrictions on PubCo shares received in the transaction.
- Eligible shareholders will receive registration rights for their PubCo shares.
Outlook, Conditions, and Risks
- The transaction could be terminated if not completed by March 23, 2022, or, if Brilliant’s corporate existence is extended, by September 23, 2022, subject to the agreement’s terms.
- Key conditions include approval by Nukkleus and Brilliant shareholders, effectiveness of the registration statement, Nasdaq listing approval, continued Nasdaq listing of Brilliant, minimum post-redemption cash, absence of a material adverse effect, compliance with debt and transaction-cost limits, and satisfaction of customary representations and covenants.
- Risks include failure to obtain shareholder or regulatory approvals, insufficient trust-fund proceeds after redemptions, failure to meet the transaction deadline, inability to maintain Nasdaq listing, legal proceedings, business disruption, employee-retention challenges, market volatility, regulatory changes, and failure to achieve post-closing business plans.
- The filing states that the proposed transaction is not an offer to sell securities or a solicitation of votes and directs investors to review the future Form S-4, proxy statement/prospectus, and related SEC filings.
Most Important Facts to Verify
- Whether the merger ultimately closed and the actual closing date.
- The final shareholder approval results and any changes to the merger agreement.
- Actual redemptions, trust-account proceeds, post-closing cash, and compliance with the $10.0 million minimum cash condition.
- The final reverse-stock-split ratio, exchange ratio, Backstop Pool allocation, and post-transaction ownership percentages.
- The final PubCo capitalization, warrant terms, transaction costs, and outstanding debt.
- The effectiveness and disclosures in the Form S-4 and proxy statement/prospectus, including risk factors and financial statements.